| __timestamp | Teva Pharmaceutical Industries Limited | Viridian Therapeutics, Inc. |
|---|---|---|
| Wednesday, January 1, 2014 | 9216000000 | 3243000 |
| Thursday, January 1, 2015 | 8296000000 | 2472000 |
| Friday, January 1, 2016 | 10044000000 | 2548000 |
| Sunday, January 1, 2017 | 11560000000 | 19623000 |
| Monday, January 1, 2018 | 10558000000 | 30421000 |
| Tuesday, January 1, 2019 | 9351000000 | 32793999 |
| Wednesday, January 1, 2020 | 8933000000 | 28304000 |
| Friday, January 1, 2021 | 8284000000 | 620000 |
| Saturday, January 1, 2022 | 7952000000 | 755000 |
| Sunday, January 1, 2023 | 8200000000 | 1322000 |
| Monday, January 1, 2024 | 8480000000 |
In pursuit of knowledge
In the ever-evolving pharmaceutical landscape, understanding cost structures is crucial. Teva Pharmaceutical Industries Limited, a global leader, and Viridian Therapeutics, Inc., an emerging player, offer intriguing insights into industry dynamics. From 2014 to 2023, Teva's cost of revenue fluctuated, peaking in 2017 at approximately $11.56 billion before declining to around $8.2 billion in 2023. This represents a 29% decrease, reflecting strategic shifts and market challenges.
Conversely, Viridian's expenses, though significantly smaller, surged by over 400% from 2014 to 2019, highlighting its aggressive growth strategy. However, a notable dip in 2021 suggests a strategic pivot or market recalibration. These trends underscore the contrasting paths of a pharmaceutical giant and a nimble biotech firm, offering valuable lessons in cost management and strategic adaptation.
Explore these insights to understand the financial narratives shaping the pharmaceutical industry today.
Cost of Revenue Trends: Bristol-Myers Squibb Company vs Teva Pharmaceutical Industries Limited
Cost of Revenue: Key Insights for Regeneron Pharmaceuticals, Inc. and Viridian Therapeutics, Inc.
Comparing Cost of Revenue Efficiency: Takeda Pharmaceutical Company Limited vs Viridian Therapeutics, Inc.
Cost of Revenue Trends: Teva Pharmaceutical Industries Limited vs Pharming Group N.V.
Cost of Revenue: Key Insights for Teva Pharmaceutical Industries Limited and Lantheus Holdings, Inc.
Cost of Revenue Comparison: Teva Pharmaceutical Industries Limited vs Veracyte, Inc.
Analyzing Cost of Revenue: Teva Pharmaceutical Industries Limited and Amphastar Pharmaceuticals, Inc.
Cost Insights: Breaking Down Teva Pharmaceutical Industries Limited and Evotec SE's Expenses
Cost of Revenue Comparison: Biogen Inc. vs Viridian Therapeutics, Inc.
Cost of Revenue Comparison: BeiGene, Ltd. vs Viridian Therapeutics, Inc.
Amneal Pharmaceuticals, Inc. vs Viridian Therapeutics, Inc.: Efficiency in Cost of Revenue Explored
Cost of Revenue: Key Insights for Wave Life Sciences Ltd. and Viridian Therapeutics, Inc.